We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $412M
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+28.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$176M
AUM Growth
-$39.5M
Cap. Flow
-$46.5M
Cap. Flow %
-26.43%
Top 10 Hldgs %
4.24%
Holding
1,468
New
111
Increased
327
Reduced
156
Closed
874

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$895K
2
EW icon
Edwards Lifesciences
EW
+$755K
3
TTEK icon
Tetra Tech
TTEK
+$745K
4
SUI icon
Sun Communities
SUI
+$733K
5
HI
Hillenbrand
HI
+$669K

Top Sells

Rank Stock Value
1
UNF icon
Unifirst Corp
UNF
+$734K
2
TGLS icon
Tecnoglass Holdings
TGLS
+$606K
3
SSNC icon
SS&C Technologies
SSNC
+$562K
4
TTEC icon
TTEC Holdings
TTEC
+$539K
5
ORGO icon
Organogenesis Holdings
ORGO
+$530K

Sector Composition

Rank Sector Weight
1 Healthcare 19.45%
2 Technology 17.59%
3 Industrials 17.3%
4 Consumer Discretionary 12.31%
5 Financials 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAGE
1451
Niagen Bioscience
NAGE
$251M
– –
-21,487
Closed -$58.7K
BERY
1452
DELISTED
Berry Global Group, Inc.
BERY
– –
-5,963
Closed -$322K
EQC
1453
DELISTED
Equity Commonwealth
EQC
– –
-358
Closed -$6.95K
AMPS
1454
DELISTED
Altus Power
AMPS
– –
-16,310
Closed -$63.9K
PYCR
1455
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
– –
-4,879
Closed -$62K
NVRO
1456
DELISTED
NEVRO CORP.
NVRO
– –
-8,876
Closed -$74.7K
ITCI
1457
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-1,268
Closed -$86.8K
FBMS
1458
DELISTED
The First Bancshares, Inc.
FBMS
– –
-4,271
Closed -$111K
NARI
1459
DELISTED
Inari Medical, Inc. Common Stock
NARI
– –
-2,316
Closed -$112K
CDMO
1460
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
– –
-30,661
Closed -$219K
HTLF
1461
DELISTED
Heartland Financial USA, Inc.
HTLF
– –
-3,097
Closed -$138K
B
1462
DELISTED
Barnes Group Inc.
B
– –
-7,412
Closed -$307K
PETQ
1463
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
– –
-4,735
Closed -$104K
CHUY
1464
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
– –
-11,748
Closed -$305K
AAN
1465
DELISTED
The Aaron's Company Inc
AAN
– –
-7,003
Closed -$69.9K
SILK
1466
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
– –
-4,637
Closed -$125K
MORF
1467
DELISTED
Morphic Holding, Inc. Common Stock
MORF
– –
-2,625
Closed -$89.4K
ENV
1468
DELISTED
ENVESTNET, INC.
ENV
– –
-1,389
Closed -$86.9K
55 56 57 58
59

Similar funds

KP
Kiltearn Partners Edinburgh, United Kingdom $412M AUM 26.77% 1-Year Est. Return
T
TOBAM Paris, France $412M AUM 18.33% 1-Year Est. Return
HP
Hilltop Partners Mishawaka, Indiana $412M AUM 26.77% 1-Year Est. Return
WIP
WealthCare Investment Partners Portsmouth, Rhode Island $412M AUM 24.95% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $412M AUM 34.27% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return
THCM
Taylor Hoffman Capital Management Richmond, Virginia $412M AUM 57.16% 1-Year Est. Return
PA
Prism Advisors Studio City, California $412M AUM 20.58% 1-Year Est. Return

EntryPoint Capital's Q3 2024 Portfolio in Review

As of Q3 2024, EntryPoint Capital held 1,468 positions worth $176M, down 18% from $215M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

EntryPoint Capital withdrew a net $46.5M in Q3 2024, closing 874 positions and reducing 156 holdings. Its most notable exit was Unifirst Corp, an estimated $734K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

Against the trend, EntryPoint Capital opened a new position in Guardant Health worth $726K.

  • EntryPoint Capital's largest Q3 2024 buy was Guardant Health: 31,633 shares worth $726K.
  • EntryPoint Capital added most to Edwards Lifesciences in Q3 2024, an estimated $755K increase.
  • EntryPoint Capital's biggest Q3 2024 reduction was Johnson & Johnson, cutting an estimated $452K.
  • EntryPoint Capital fully exited Unifirst Corp in Q3 2024, selling an estimated $734K.
  • EntryPoint Capital's ten largest holdings make up 4.2% of its $176M portfolio in Q3 2024.
  • EntryPoint Capital opened 111 new positions and closed 874 in Q3 2024.
  • EntryPoint Capital's portfolio value fell 18% quarter-over-quarter to $176M.

Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.